259 related articles for article (PubMed ID: 16399211)
1. Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease.
Guidi I; Galimberti D; Lonati S; Novembrino C; Bamonti F; Tiriticco M; Fenoglio C; Venturelli E; Baron P; Bresolin N; Scarpini E
Neurobiol Aging; 2006 Feb; 27(2):262-9. PubMed ID: 16399211
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment.
Pesaresi M; Lovati C; Bertora P; Mailland E; Galimberti D; Scarpini E; Quadri P; Forloni G; Mariani C
Neurobiol Aging; 2006 Jun; 27(6):904-5. PubMed ID: 16638622
[TBL] [Abstract][Full Text] [Related]
3. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
Hernanz A; De la Fuente M; Navarro M; Frank A
Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
[TBL] [Abstract][Full Text] [Related]
4. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
[TBL] [Abstract][Full Text] [Related]
5. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.
Markesbery WR; Kryscio RJ; Lovell MA; Morrow JD
Ann Neurol; 2005 Nov; 58(5):730-5. PubMed ID: 16240347
[TBL] [Abstract][Full Text] [Related]
6. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.
Kim TS; Lim HK; Lee JY; Kim DJ; Park S; Lee C; Lee CU
Neurosci Lett; 2008 May; 436(2):196-200. PubMed ID: 18378084
[TBL] [Abstract][Full Text] [Related]
7. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
[TBL] [Abstract][Full Text] [Related]
8. Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment.
Mauri M; Sinforiani E; Bono G; Cittadella R; Quattrone A; Boller F; Nappi G
Funct Neurol; 2006; 21(4):223-8. PubMed ID: 17367583
[TBL] [Abstract][Full Text] [Related]
9. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment.
Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
Free Radic Res; 2008 Feb; 42(2):162-70. PubMed ID: 18297609
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A
Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia in Alzheimer dementia patients and cognitive decline after 6 months follow-up period.
Tu MC; Huang CW; Chen NC; Chang WN; Lui CC; Chen CF; Chen C; Wang YL; Lin YT; Chang CC
Acta Neurol Taiwan; 2010 Sep; 19(3):168-77. PubMed ID: 20824536
[TBL] [Abstract][Full Text] [Related]
12. Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
Lovell MA; Markesbery WR
J Neurosci Res; 2007 Nov; 85(14):3036-40. PubMed ID: 17510979
[TBL] [Abstract][Full Text] [Related]
13. Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease.
Alvarez A; Cacabelos R; Sanpedro C; García-Fantini M; Aleixandre M
Neurobiol Aging; 2007 Apr; 28(4):533-6. PubMed ID: 16569464
[TBL] [Abstract][Full Text] [Related]
14. Oxidative LDL modification is increased in vascular dementia and is inversely associated with cognitive performance.
Li L; Willets RS; Polidori MC; Stahl W; Nelles G; Sies H; Griffiths HR
Free Radic Res; 2010 Mar; 44(3):241-8. PubMed ID: 20166891
[TBL] [Abstract][Full Text] [Related]
15. Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease.
Jung SM; Lee K; Lee JW; Namkoong H; Kim HK; Kim S; Na HR; Ha SA; Kim JR; Ko J; Kim JW
Neurosci Lett; 2008 May; 436(2):153-7. PubMed ID: 18378077
[TBL] [Abstract][Full Text] [Related]
16. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.
Paragh G; Balla P; Katona E; Seres I; Egerházi A; Degrell I
Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):63-7. PubMed ID: 12111338
[TBL] [Abstract][Full Text] [Related]
17. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.
Buchhave P; Janciauskiene S; Zetterberg H; Blennow K; Minthon L; Hansson O
Neurosci Lett; 2009 Jan; 450(1):56-9. PubMed ID: 18996438
[TBL] [Abstract][Full Text] [Related]
19. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
